What is Nccrm?
Established in 1992, the North Carolina Center for Reproductive Medicine (NCCRM) operates as a premier provider of comprehensive fertility treatments. The firm distinguishes itself through a clinical focus on high-success-rate procedures, including In Vitro Fertilization (IVF), tubal ligation reversal, and specialized male infertility interventions. By prioritizing a patient-centric model that balances medical sophistication with financial accessibility, NCCRM has carved out a significant niche in the reproductive health landscape. The organization's commitment to personalized care pathways ensures that it remains a competitive entity in an industry increasingly defined by technological innovation and the demand for high-quality, compassionate reproductive services.
How much funding has Nccrm raised?
Nccrm has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Nccrm
PPP
Public-Private Partnership
What's next for Nccrm?
With the successful closure of this late-stage funding round, NCCRM is well-positioned to scale its clinical operations and invest in next-generation reproductive technologies. The strategic deployment of this capital will likely focus on enhancing laboratory capabilities, optimizing patient acquisition channels, and potentially expanding its geographic footprint to address the growing demand for fertility services. As the reproductive medicine market continues to evolve, NCCRM's ability to integrate advanced diagnostic tools with its established care protocols will be critical in maintaining its leadership status. Future growth trajectories will likely emphasize operational efficiency and the continued refinement of its service offerings to meet the complex needs of modern families.
See full Nccrm company page
